Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
26
pubmed:dateCreated
1993-10-7
pubmed:abstractText
We have generated a novel "receptor tyrosine kinase" by fusing the extracellular and transmembrane domain of the mouse platelet-derived growth factor receptor (PDGFR) to the cytoplasmic domain of CD4 and coexpressing the construct with the murine cytoplasmic tyrosine protein kinase p56lck. NMuMG cells, which are mouse mammary gland epithelial cells that lack endogenous platelet-derived growth factor (PDGF) receptor expression, were stably transfected with both PDGFR-CD4 and p56lck. The PDGFR-CD4 chimeric protein was expressed at the cell surface and formed a complex with p56lck. Addition of PDGF to these cells led to increased tyrosine phosphorylation of a 56-kDa protein likely to be p56lck and several unidentified cellular proteins. The enzymatic activity of p56lck was increased after treatment with PDGF, indicating that dimerization (or oligomerization) mediated by ligand binding at the cell surface is capable of inducing the activation not only of receptor tyrosine kinases but nonreceptor tyrosine kinases as well. However, the PDGFR-CD4.p56lck complex was, in contrast to the wild type PDGF receptor, not able to induce a PDGF-dependent mitogenic response or DNA synthesis in NMuMG cells. Analysis of several known substrates of the PDGFR-signaling pathway indicates an early block in the transduction of the signal generated by p56lck.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Sep
pubmed:issn
0021-9258
pubmed:author
pubmed:issnType
Print
pubmed:day
15
pubmed:volume
268
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
19882-8
pubmed:dateRevised
2009-11-19
pubmed:meshHeading
pubmed-meshheading:8366126-Amino Acid Sequence, pubmed-meshheading:8366126-Animals, pubmed-meshheading:8366126-Antigens, CD4, pubmed-meshheading:8366126-Base Sequence, pubmed-meshheading:8366126-Cell Line, pubmed-meshheading:8366126-Cell Membrane, pubmed-meshheading:8366126-Growth Inhibitors, pubmed-meshheading:8366126-Humans, pubmed-meshheading:8366126-Kinetics, pubmed-meshheading:8366126-Lymphocyte Specific Protein Tyrosine Kinase p56(lck), pubmed-meshheading:8366126-Mice, pubmed-meshheading:8366126-Molecular Sequence Data, pubmed-meshheading:8366126-Phosphorylation, pubmed-meshheading:8366126-Plasmids, pubmed-meshheading:8366126-Platelet-Derived Growth Factor, pubmed-meshheading:8366126-Protein Binding, pubmed-meshheading:8366126-Protein-Tyrosine Kinases, pubmed-meshheading:8366126-Receptors, Platelet-Derived Growth Factor, pubmed-meshheading:8366126-Recombinant Fusion Proteins, pubmed-meshheading:8366126-Signal Transduction, pubmed-meshheading:8366126-Transfection
pubmed:year
1993
pubmed:articleTitle
Signal transduction through a biomolecular receptor tyrosine protein kinase composed of a platelet-derived growth factor receptor-CD4 chimera and the nonreceptor tyrosine protein kinase Lck.
pubmed:affiliation
Department of Molecular Biology, Bristol-Myers Squibb Pharmaceutical Research Institute, Princeton, New Jersey 08543-4000.
pubmed:publicationType
Journal Article, Comparative Study, Research Support, Non-U.S. Gov't